Mylan Laboratories, Inc. (NASDAQ:MYL)

CAPS Rating: 4 out of 5

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Recs

0
Player Avatar cashman79 (38.14) Submitted: 9/15/2010 9:55:36 AM : Outperform Start Price: $17.92 MYL Score: +3.18

watch

Featured Broker Partners


Advertisement